Welcome: Guest

log in

Stock Market Efficiency, Insider Dealing and Market Abuse

Publication Date February 2009
Publisher Ashgate Publishing
Product Type Book
Pages 224
ISBN Number 9780566088490
Product Code ASH00455
Buy this product or for assistance call +44 20 7060 7474

Summary

The recent turbulence in the stock market has brought into question the way, and prices at which, shares are traded, and how the market effectively values companies. It has also raised public concern as to the way by which dealers and investors take advantage of changes in market prices.

A number of high profile criminal prosecutions of insider dealing and market abuse and the frequent claims of other instances, combined with the changes in regulations resulting in a more aggressive and proactive stance by the various regulators, have brought the issue under the spotlight.

This book discusses what makes stock market efficiency so important for the economy, looks at the theory and issues that underpin market abuse and why an offence often dismissed as a victimless crime is punished so severely. It explores the impact of perception and other factors that distort the market and outlines the extent of abuse.

Regulators, lawyers, company officials, investigators, professional advisers and of course investors, both professional and otherwise will find this a helpful guide to the underlying elements of fraud and market manipulation.

Content

  • Introduction
  • Why the Stock Market and Its Efficiency are so Important
  • How Shares are Traded and Valued
  • The Efficient Capital Markets Hypothesis
  • Market Irrationality: Bubbles, Manias, Panics and Crashes
  • Outperforming the Market: the Case of Mergers and Takeovers
  • The Regulation of the Markets
  • Market Abuse
  • The Role, Use and Abuse of Financial and Accounting Data: Information Asymmetry
  • The Way Forward
  • Index.
Delivery Details

PRINT/CD-ROM:Despatched within 1 to 2 working days.

Industry Events

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>